Tracing Spatiotemporal T790M Heterogeneity in Patients with EGFR-Mutant Advanced NSCLC after Acquired Resistance to EGFR TKIs

被引:0
|
作者
Zhang, Yi-Chen
Pi, Can
Ke, E-E
Chen, Zhi-Hong
Su, Jian
Dong, Zhong-Yi
Xu, Chong-Rui
Tu, Hai-Yan
Yan, Hong-Hong
Zhong, Wen-Zhao
Yang, Jin-Ji
Zhang, Xu-Chao
Wu, Yi Long
Zhou, Qing
机构
[1] Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] GGH, Guangzhou, Guangdong, Peoples R China
[3] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
关键词
Acquired resistance; EGFR TKIs; spatiotemporal heterogeneity; T790M;
D O I
10.1016/j.jtho.2016.11.1762
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.02b-095
引用
收藏
页码:S1249 / S1249
页数:1
相关论文
共 50 条
  • [1] Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non-Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI
    Hata, Akito
    Katakami, Nobuyuki
    Yoshioka, Hiroshige
    Kaji, Reiko
    Masago, Katsuhiro
    Fujita, Shiro
    Imai, Yukihiro
    Nishiyama, Akihiro
    Ishida, Tadashi
    Nishimura, Yoshihiro
    Yatabe, Yasushi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (11) : 1553 - 1559
  • [2] Detection of the T790M Mutation of EGFR in Plasma of Advanced NSCLC Patients with Acquired Resistance to EGFR-TKI (WJOG8014LTR)
    Azuma, Koichi
    Takahama, Takayuki
    Sakai, Kazuko
    Takeda, Masayuki
    Hida, Toyoaki
    Hirabayashi, Masataka
    Oguri, Tetsuya
    Tanaka, Hiroshi
    Ebi, Noriyuki
    Sawa, Toshiyuki
    Bessho, Akihiro
    Tachihara, Motoko
    Akamatsu, Hiroaki
    Bandoh, Shuji
    Himeji, Daisuke
    Ohira, Tatsuo
    Shimokawa, Mototsugu
    Yamamoto, Nobuyuki
    Nakanishi, Yoichi
    Nakagawa, Kazuhiko
    Nishio, Kazuto
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S389 - S390
  • [3] The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M
    Tseng, Jeng-Sen
    Su, Kang-Yi
    Yang, Tsung-Ying
    Chen, Kun-Chieh
    Hsu, Kuo-Hsuan
    Chen, Hsuan-Yu
    Tsai, Chi-Ren
    Yu, Sung-Liang
    Chang, Gee-Chen
    ONCOTARGET, 2016, 7 (30) : 48059 - 48069
  • [4] Clinical Likelihood of Sporadic Primary EGFR T790M Mutation in EGFR-Mutant Lung Cancer
    Lee, Youngjoo
    Lee, Geon Kook
    Hwang, Jung-Ah
    Yun, Tak
    Kim, Heung Tae
    Lee, Jin Soo
    CLINICAL LUNG CANCER, 2015, 16 (01) : 46 - 50
  • [5] The Effect of Metformin on Survival Outcomes of Advanced EGFR-mutant NSCLC Patients Treated with EGFR TKIs in Thailand
    Saichaemchan, S.
    Kanjanavithayakul, Y.
    Prasongsook, N.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S484 - S485
  • [6] Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma
    Su, Kang-Yi
    Tseng, Jeng-Sen
    Liao, Keng-Mao
    Yang, Tsung-Ying
    Chen, Kun-Chieh
    Hsu, Kuo-Hsuan
    Yang, Pan-Chyr
    Yu, Sung-Liang
    Chang, Gee-Chen
    PLOS ONE, 2018, 13 (11):
  • [7] Role of T790M Mutation in EGFR-TKI Rechallenge for Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer
    Zhang, Qiu-Yi
    Ke, E-E
    Deng, Wei
    Niu, Fei-Yu
    Zhao, Ning
    Su, Jian
    Chen, Zhi-Hong
    Yang, Jin-Ji
    Xu, Chong-Rui
    Yan, Hong-Hong
    Wu, Yi-Long
    Zhou, Qing
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S271 - S271
  • [8] Comprehensive Analysis of EGFR-Mutant Abundance and Its Effect on Efficacy of EGFR TKIs in Advanced NSCLC with EGFR Mutations
    Li, Xuefei
    Cai, Weijing
    Yang, Guohua
    Su, Chunxia
    Ren, Shengxiang
    Zhao, Chao
    Hu, Rongjun
    Chen, Xiaoxia
    Gao, Guanghui
    Guo, Zhiwei
    Li, Wei
    Zhou, Caicun
    Hirsch, Fred R.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (09) : 1388 - 1397
  • [9] Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors
    Huang, Chun-Ta
    Lin, Chih-An
    Su, Te-Jen
    Yang, Ching-Yao
    Tsai, Tzu-Hsiu
    Hsu, Chia-Lin
    Liao, Wei-Yu
    Chen, Kuan-Yu
    Ho, Chao-Chi
    Yu, Chong-Jen
    BMC CANCER, 2023, 23 (01)
  • [10] Different treatment efficacies and T790M acquisition of EGFR-TKIs on NSCLC patients with variable Del-19 subtypes of EGFR
    Wu, Shang-Gin
    Gow, Chien-Hung
    Chen, Yi-Ling
    Liu, Yi-Nan
    Tsai, Meng-Feng
    Shih, Jin-Yuan
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (02) : 352 - 363